| Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients J Hadjadj, N Yatim, L Barnabei, A Corneau, J Boussier, N Smith, H Péré, ... Science 369 (6504), 718-724, 2020 | 2958 | 2020 |
| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2524 | 2020 |
| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 900 | 2021 |
| Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data M Mahévas, VT Tran, M Roumier, A Chabrol, R Paule, C Guillaud, E Fois, ... Bmj 369, 2020 | 493 | 2020 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 464 | 2021 |
| Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French autoimmunity and rituximab registry B Terrier, Z Amoura, P Ravaud, E Hachulla, R Jouenne, B Combe, ... Arthritis & Rheumatism 62 (8), 2458-2466, 2010 | 455 | 2010 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 342 | 2021 |
| Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C–related mixed cryoglobulinemia D Saadoun, M Resche Rigon, D Sene, B Terrier, A Karras, L Perard, ... Blood, The Journal of the American Society of Hematology 116 (3), 326-334, 2010 | 329 | 2010 |
| Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin Y Allenbach, L Drouot, A Rigolet, JL Charuel, F Jouen, NB Romero, ... Medicine 93 (3), 150-157, 2014 | 320 | 2014 |
| Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled … P Charles, B Terrier, É Perrodeau, P Cohen, S Faguer, A Huart, ... Annals of the rheumatic diseases 77 (8), 1143-1149, 2018 | 307 | 2018 |
| IgA vasculitis (Henoch–Shönlein purpura) in adults: Diagnostic and therapeutic aspects A Audemard-Verger, E Pillebout, L Guillevin, E Thervet, B Terrier Autoimmunity reviews 14 (7), 579-585, 2015 | 284 | 2015 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 282 | 2021 |
| Serum neutralization of SARS-CoV-2 Omicron sublineages BA. 1 and BA. 2 in patients receiving monoclonal antibodies T Bruel, J Hadjadj, P Maes, D Planas, A Seve, I Staropoli, ... Nature medicine 28 (6), 1297-1302, 2022 | 266 | 2022 |
| Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients DM Smadja, CL Guerin, R Chocron, N Yatim, J Boussier, N Gendron, ... Angiogenesis 23, 611-620, 2020 | 259 | 2020 |
| No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection and requiring oxygen: results of a study using routinely collected data … M Mahévas, VT Tran, M Roumier, A Chabrol, R Paule, C Guillaud, ... medrxiv, 2020.04. 10.20060699, 2020 | 256 | 2020 |
| Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease G Geri, B Terrier, M Rosenzwajg, B Wechsler, M Touzot, D Seilhean, ... Journal of Allergy and Clinical Immunology 128 (3), 655-664, 2011 | 251 | 2011 |
| Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey B Terrier, E Krastinova, I Marie, D Launay, A Lacraz, P Belenotti, ... Blood, The Journal of the American Society of Hematology 119 (25), 5996-6004, 2012 | 239 | 2012 |
| Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation B Terrier, N Derian, Y Schoindre, W Chaara, G Geri, N Zahr, ... Arthritis research & therapy 14, 1-10, 2012 | 238 | 2012 |
| Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients S Georgin‐Lavialle, B Terrier, AF Guedon, M Heiblig, T Comont, E Lazaro, ... British Journal of Dermatology 186 (3), 564-574, 2022 | 237 | 2022 |
| Th1 and Th17 cytokines drive inflammation in Takayasu arteritis D Saadoun, M Garrido, C Comarmond, AC Desbois, F Domont, L Savey, ... Arthritis & rheumatology 67 (5), 1353-1360, 2015 | 225 | 2015 |
